ScreenerHero

VINCVincerx Pharma, Inc.

NAS · US · Healthcare · Biotechnology · vincerx.com
0.0130USD0.00%Mkt Cap: 68045 $P/E: —

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx b…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap68.05K $
Enterprise Value-4.37M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-30.07M $
Revenue/Share—
Last Price0.0130 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA0.18
EV/Revenue—
P/S—
P/B0.03
EPS (TTM)-5.79
EPS (Forward)-0.67
52W Range
0.001016% of range0.0740
52W High0.0740 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1104.04%
ROA-375.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.13M $
CapEx (TTM)—
FCF Margin—
FCF Yield-23317.47%
Net Debt-4.44M $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.00
Current Ratio1.79
Quick Ratio1.69
Book Value/Sh0.3950 USD
Cash/Share0.8480 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJan 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.23M
Float4.75M
Insiders4.11%
Institutions5.25%
Short Interest
Short Ratio0.1d
Short % Float2.72%
Short % Out.2.62%
Shares Short137.20K
Short (prev mo.)191.88K
Technical
SMA 500.0131 (-0.9%)
SMA 2000.0125 (+3.6%)
Beta1.40
S&P 52W Chg18.16%
Avg Vol (30d)5.76K
Avg Vol (10d)800
Technical Indicators
RSI (14)45.0
MACD-0.0001
MACD Signal-0.0001
MACD Hist.-0.0000
BB Upper0.0140 USD
BB Middle0.0131 USD
BB Lower0.0122 USD
BB Width13.66%
ATR (14)0.0001 USD
Vol Ratio (20d)0.00x